Phytochemical regulation of Fyn and AMPK signaling circuitry

Archives of Pharmacal Research

Volumn 38, Issue 12, 2015, Pages 2093-2105

  Lee, Chan Gyu ^a   Koo, Ja Hyun ^a   Kim, Sang Geon ^a  

^a Seoul National University   (South Korea)

Author keywords

AMPK; Antioxidant; Fyn; Metabolic disease; Phytochemical

Indexed keywords

ADENYLATE KINASE; BERBERINE; CAFFEIC ACID; CURCUMIN; DELPHINIDIN; DITHIOTHREITOL; EPIGALLOCATECHIN GALLATE; GENISTEIN; KAZINOL DERIVATIVE; LIGNAN DERIVATIVE; MYRICETIN; PLANT MEDICINAL PRODUCT; POLYPHENOL DERIVATIVE; PROTEIN KINASE FYN; QUERCETIN; RESVERATROL; ROSMARINIC ACID; SAUCHINONE; UNCLASSIFIED DRUG; FYN PROTEIN, HUMAN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; CELL SURVIVAL; CHEMICAL STRUCTURE; ENERGY CONSERVATION; ENZYME INHIBITION; FATTY ACID OXIDATION; GLUCOSE TRANSPORT; HUMAN; METABOLIC DISORDER; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHYTOCHEMISTRY; PRENYLATION; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; TISSUE INJURY; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMISTRY; DRUG EFFECTS; METABOLIC DISEASES; METABOLISM; PHYSIOLOGY;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; HUMANS; METABOLIC DISEASES; PHYTOCHEMICALS; PROTO-ONCOGENE PROTEINS C-FYN; SIGNAL TRANSDUCTION;

EID: 84948720915     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-015-0611-x     Document Type: Review

References (121)

1. Abe, J., and B.C. Berk. 1999. Fyn and JAK2 mediate Ras activation by reactive oxygen species. Journal of Biological Chemistry 274(30): 21003-21010.
2. Adams, J., Z.P. Chen, B.J. Van Denderen, C.J. Morton, M.W. Parker, L.A. Witters, D. Stapleton, and B.E. Kemp. 2004. Intrasteric control of AMPK via the gamma1 subunit AMP allosteric regulatory site. Protein Science 13(1): 155-165. doi: 10.1110/ps.03340004.
3. Aggarwal, B.B., and K.B. Harikumar. 2009. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. International Journal of Biochemistry & Cell Biology 41(1): 40-59. doi: 10.1016/j.biocel.2008.06.010.
4. Akiyama, T., J. Ishida, S. Nakagawa, H. Ogawara, S. Watanabe, N. Itoh, M. Shibuya, and Y. Fukami. 1987. Genistein, a specific inhibitor of tyrosine-specific protein kinases. Journal of Biological Chemistry 262(12): 5592-5595.
5. Alessi, D.R., K. Sakamoto, and J.R. Bayascas. 2006. LKB1-dependent signaling pathways. Annual Review of Biochemistry 75: 137-163. doi: 10.1146/annurev.biochem.75.103004.142702.
6. Anand, P., S.G. Thomas, A.B. Kunnumakkara, C. Sundaram, K.B. Harikumar, B. Sung, S.T. Tharakan, K. Misra, I.K. Priyadarsini, K.N. Rajasekharan, and B.B. Aggarwal. 2008. Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature. Biochemical Pharmacology 76(11): 1590-1611. doi: 10.1016/j.bcp.2008.08.008.
7. Ascherio, A., M.G. Weisskopf, E.J. O'Reilly, M.L. McCullough, E.E. Calle, C. Rodriguez, and M.J. Thun. 2004. Coffee consumption, gender, and Parkinson's disease mortality in the cancer prevention study II cohort: The modifying effects of estrogen. American Journal of Epidemiology 160(10): 977-984. doi: 10.1093/aje/kwh312.
8. Baas, A.F., J. Boudeau, G.P. Sapkota, L. Smit, R. Medema, N.A. Morrice, D.R. Alessi, and H.C. Clevers. 2003. Activation of the tumour suppressor kinase LKB1 by the STE20-like pseudokinase STRAD. EMBO Journal 22(12): 3062-3072. doi: 10.1093/emboj/cdg292.
9. Bastie, C.C., H. Zong, J. Xu, B. Busa, S. Judex, I.J. Kurland, and J.E. Pessin. 2007. Integrative metabolic regulation of peripheral tissue fatty acid oxidation by the SRC kinase family member Fyn. Cell Metabolism 5(5): 371-381. doi: 10.1016/j.cmet.2007.04.005.
10. Baur, J.A., and D.A. Sinclair. 2006. Therapeutic potential of resveratrol: The in vivo evidence. Nature Reviews Drug Discovery 5(6): 493-506. doi: 10.1038/nrd2060.
11. Boggon, T.J., and M.J. Eck. 2004. Structure and regulation of Src family kinases. Oncogene 23(48): 7918-7927. doi: 10.1038/sj.onc.1208081.
12. Boney, C.M., H. Sekimoto, P.A. Gruppuso, and A.R. Frackelton Jr. 2001. Src family tyrosine kinases participate in insulin-like growth factor I mitogenic signaling in 3T3-L1 cells. Cell Growth & Differentiation 12(7): 379-386.
13. Botta, B., A. Vitali, P. Menendez, D. Misiti, and G. Delle Monache. 2005. Prenylated flavonoids: Pharmacology and biotechnology. Current Medicinal Chemistry 12(6): 717-739.
14. Bromann, P.A., H. Korkaya, and S.A. Courtneidge. 2004. The interplay between Src family kinases and receptor tyrosine kinases. Oncogene 23(48): 7957-7968. doi: 10.1038/sj.onc.1208079.
15. Bulzomi, P., P. Galluzzo, A. Bolli, S. Leone, F. Acconcia, and M. Marino. 2012. The pro-apoptotic effect of quercetin in cancer cell lines requires ERbeta-dependent signals. Journal of Cellular Physiology 227(5): 1891-1898. doi: 10.1002/jcp.22917.
16. Burns, J., T. Yokota, H. Ashihara, M.E. Lean, and A. Crozier. 2002. Plant foods and herbal sources of resveratrol. Journal of Agriculture and Food Chemistry 50(11): 3337-3340.
17. Canto, C., Z. Gerhart-Hines, J.N. Feige, M. Lagouge, L. Noriega, J.C. Milne, P.J. Elliott, P. Puigserver, and J. Auwerx. 2009. AMPK regulates energy expenditure by modulating NAD + metabolism and SIRT1 activity. Nature 458(7241): 1056-1060. doi: 10.1038/nature07813.
18. Cheadle, C., Y. Ivashchenko, V. South, G.H. Searfoss, S. French, R. Howk, G.A. Ricca, and M. Jaye. 1994. Identification of a Src SH3 domain binding motif by screening a random phage display library. Journal of Biological Chemistry 269(39): 24034-24039.
19. Choi, S.H., Y.M. Kim, J.M. Lee, and S.G. Kim. 2010a. Antioxidant and mitochondrial protective effects of oxidized metabolites of oltipraz. Expert Opinion on Drug Metabolism & Toxicology 6(2): 213-224. doi: 10.1517/17425250903427972.
20. Choi, S.H., Y.W. Kim, and S.G. Kim. 2010b. AMPK-mediated GSK3beta inhibition by isoliquiritigenin contributes to protecting mitochondria against iron-catalyzed oxidative stress. Biochemical Pharmacology 79(9): 1352-1362. doi: 10.1016/j.bcp.2009.12.011.
21. Choudhury, G.G., L. Mahimainathan, F. Das, B. Venkatesan, and N. Ghosh-Choudhury. 2006. c-Src couples PI 3 kinase/Akt and MAPK signaling to PDGF-induced DNA synthesis in mesangial cells. Cellular Signalling 18(11): 1854-1864. doi: 10.1016/j.cellsig.2006.02.003.
22. Christofk, H.R., M.G. Vander Heiden, N. Wu, J.M. Asara, and L.C. Cantley. 2008. Pyruvate kinase M2 is a phosphotyrosine-binding protein. Nature 452(7184): 181-186. doi: 10.1038/nature06667.
23. Citri, A., D. Harari, G. Shohat, P. Ramakrishnan, J. Gan, S. Lavi, M. Eisenstein, A. Kimchi, D. Wallach, S. Pietrokovski, and Y. Yarden. 2006. Hsp90 recognizes a common surface on client kinases. Journal of Biological Chemistry 281(20): 14361-14369. doi: 10.1074/jbc.M512613200.
24. Collins, Q.F., H.Y. Liu, J. Pi, Z. Liu, M.J. Quon, and W. Cao. 2007. Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, suppresses hepatic gluconeogenesis through 5′-AMP-activated protein kinase. Journal of Biological Chemistry 282(41): 30143-30149. doi: 10.1074/jbc.M702390200.
25. Cowan-Jacob, S.W., G. Fendrich, P.W. Manley, W. Jahnke, D. Fabbro, J. Liebetanz, and T. Meyer. 2005. The crystal structure of a c-Src complex in an active conformation suggests possible steps in c-Src activation. Structure 13(6): 861-871. doi: 10.1016/j.str.2005.03.012.
26. Culmsee, C., J. Monnig, B.E. Kemp, and M.P. Mattson. 2001. AMP-activated protein kinase is highly expressed in neurons in the developing rat brain and promotes neuronal survival following glucose deprivation. Journal of Molecular Neuroscience 17(1): 45-58. doi: 10.1385/JMN:17:1:45.
27. Dasgupta, B., and J. Milbrandt. 2007. Resveratrol stimulates AMP kinase activity in neurons. Proceedings of the National Academy of Sciences of the United States of America 104(17): 7217-7222. doi: 10.1073/pnas.0610068104.
28. da Lee, Y., H. do Kim, H.J. Lee, Y. Lee, K.H. Ryu, B.I. Jung, Y.S. Song, and J.H. Ryu. 2010. New estrogenic compounds isolated from Broussonetia kazinoki. Bioorganic & Medicinal Chemistry Letters 20(12): 3764-3767. doi: 10.1016/j.bmcl.2010.04.064.
29. Eberl, G., B. Lowin-Kropf, and H.R. MacDonald. 1999. Cutting edge: NKT cell development is selectively impaired in Fyn- deficient mice. Journal of Immunology 163(8): 4091-4094.
30. Food, and H. H. S. Drug Administration. 2008. Food labeling: Health claims; soluble fiber from certain foods and risk of coronary heart disease. Final rule. Federal Register 73(159): 47828-47829.
31. Fujiwara, H., M. Hosokawa, X. Zhou, S. Fujimoto, K. Fukuda, K. Toyoda, Y. Nishi, Y. Fujita, K. Yamada, Y. Yamada, Y. Seino, and N. Inagaki. 2008. Curcumin inhibits glucose production in isolated mice hepatocytes. Diabetes Research and Clinical Practice 80(2): 185-191. doi: 10.1016/j.diabres.2007.12.004.
32. Fulco, M., Y. Cen, P. Zhao, E.P. Hoffman, M.W. McBurney, A.A. Sauve, and V. Sartorelli. 2008. Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. Developmental Cell 14(5): 661-673. doi: 10.1016/j.devcel.2008.02.004.
33. Fulco, M., and V. Sartorelli. 2008. Comparing and contrasting the roles of AMPK and SIRT1 in metabolic tissues. Cell Cycle 7(23): 3669-3679.
34. Gadue, P., N. Morton, and P.L. Stein. 1999. The Src family tyrosine kinase Fyn regulates natural killer T cell development. Journal of Experimental Medicine 190(8): 1189-1196.
35. Gan, R.Y., and H.B. Li. 2014. Recent progress on liver kinase B1 (LKB1): Expression, regulation, downstream signaling and cancer suppressive function. International Journal of Molecular Sciences 15(9): 16698-16718. doi: 10.3390/ijms150916698.
36. Han, C.Y., S.H. Ki, Y.W. Kim, K. Noh, Y. da Lee, B. Kang, J.H. Ryu, R. Jeon, E.H. Kim, S.J. Hwang, and S.G. Kim. 2011. Ajoene, a stable garlic by-product, inhibits high fat diet-induced hepatic steatosis and oxidative injury through LKB1-dependent AMPK activation. Antioxidants & Redox Signaling 14(2): 187-202. doi: 10.1089/ars.2010.3190.
37. Hardie, D.G. 2004. AMP-activated protein kinase: A master switch in glucose and lipid metabolism. Reviews in Endocrine and Metabolic Disorders 5(2): 119-125. doi: 10.1023/B:REMD.0000021433.63915.bb.
38. Hawley, S.A., M. Davison, A. Woods, S.P. Davies, R.K. Beri, D. Carling, and D.G. Hardie. 1996. Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. Journal of Biological Chemistry 271(44): 27879-27887.
39. Hayashi, T., M.F. Hirshman, N. Fujii, S.A. Habinowski, L.A. Witters, and L.J. Goodyear. 2000. Metabolic stress and altered glucose transport: Activation of AMP-activated protein kinase as a unifying coupling mechanism. Diabetes 49(4): 527-531.
40. He, Z., F. Tang, S. Ermakova, M. Li, Q. Zhao, Y.Y. Cho, W.Y. Ma, H.S. Choi, A.M. Bode, C.S. Yang, and Z. Dong. 2008. Fyn is a novel target of (-)-epigallocatechin gallate in the inhibition of JB6 Cl41 cell transformation. Molecular Carcinogenesis 47(3): 172-183. doi: 10.1002/mc.20299.
41. Hirano, T., K. Oka, and M. Akiba. 1989. Effects of synthetic and naturally occurring flavonoids on Na+, K+ -ATPase: Aspects of the structure-activity relationship and action mechanism. Life Sciences 45(12): 1111-1117.
42. Hou, D.X., and T. Kumamoto. 2010. Flavonoids as protein kinase inhibitors for cancer chemoprevention: Direct binding and molecular modeling. Antioxidants & Redox Signaling 13(5): 691-719. doi: 10.1089/ars.2009.2816.
43. Hou, X., S. Xu, K.A. Maitland-Toolan, K. Sato, B. Jiang, Y. Ido, F. Lan, K. Walsh, M. Wierzbicki, T.J. Verbeuren, R.A. Cohen, and M. Zang. 2008. SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase. Journal of Biological Chemistry 283(29): 20015-20026. doi: 10.1074/jbc.M802187200.
44. Hwang, J.T., M.S. Lee, H.J. Kim, M.J. Sung, H.Y. Kim, M.S. Kim, and D.Y. Kwon. 2009a. Antiobesity effect of ginsenoside Rg3 involves the AMPK and PPAR-gamma signal pathways. Phytotherapy Research 23(2): 262-266. doi: 10.1002/ptr.2606.
45. Hwang, M.K., N.J. Kang, Y.S. Heo, K.W. Lee, and H.J. Lee. 2009b. Fyn kinase is a direct molecular target of delphinidin for the inhibition of cyclooxygenase-2 expression induced by tumor necrosis factor-alpha. Biochemical Pharmacology 77(7): 1213-1222. doi: 10.1016/j.bcp.2008.12.021.
46. Jain, A.K., and A.K. Jaiswal. 2007. GSK-3beta acts upstream of Fyn kinase in regulation of nuclear export and degradation of NF-E2 related factor 2. Journal of Biological Chemistry 282(22): 16502-16510. doi: 10.1074/jbc.M611336200.
47. Janssen, K., R.P. Mensink, F.J. Cox, J.L. Harryvan, R. Hovenier, P.C. Hollman, and M.B. Katan. 1998. Effects of the flavonoids quercetin and apigenin on hemostasis in healthy volunteers: Results from an in vitro and a dietary supplement study. American Journal of Clinical Nutrition 67(2): 255-262.
48. Jelic, D., B. Mildner, S. Kostrun, K. Nujic, D. Verbanac, O. Culic, R. Antolovic, and W. Brandt. 2007. Homology modeling of human Fyn kinase structure: Discovery of rosmarinic acid as a new Fyn kinase inhibitor and in silico study of its possible binding modes. Journal of Medicinal Chemistry 50(6): 1090-1100. doi: 10.1021/jm0607202.
49. Johnson, L.N., M.E. Noble, and D.J. Owen. 1996. Active and inactive protein kinases: Structural basis for regulation. Cell 85(2): 149-158.
50. Joo, M.S., C.G. Lee, J.H. Koo, and S.G. Kim. 2013. miR-125b transcriptionally increased by Nrf2 inhibits AhR repressor, which protects kidney from cisplatin-induced injury. Cell Death and Disease 4: e899. doi: 10.1038/cddis.2013.427.
51. Jung, S.K., K.W. Lee, S. Byun, N.J. Kang, S.H. Lim, Y.S. Heo, A.M. Bode, G.T. Bowden, H.J. Lee, and Z. Dong. 2008. Myricetin suppresses UVB-induced skin cancer by targeting Fyn. Cancer Research 68(14): 6021-6029. doi: 10.1158/0008-5472.CAN-08-0899.
52. Kang, N.J., K.W. Lee, B.J. Shin, S.K. Jung, M.K. Hwang, A.M. Bode, Y.S. Heo, H.J. Lee, and Z. Dong. 2009. Caffeic acid, a phenolic phytochemical in coffee, directly inhibits Fyn kinase activity and UVB-induced COX-2 expression. Carcinogenesis 30(2): 321-330. doi: 10.1093/carcin/bgn282.
53. Kaspar, J.W., and A.K. Jaiswal. 2011. Tyrosine phosphorylation controls nuclear export of Fyn, allowing Nrf2 activation of cytoprotective gene expression. FASEB Journal 25(3): 1076-1087. doi: 10.1096/fj.10-171553.
54. Kemper, J.K., Z. Xiao, B. Ponugoti, J. Miao, S. Fang, D. Kanamaluru, S. Tsang, S.Y. Wu, C.M. Chiang, and T.D. Veenstra. 2009. FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states. Cell Metabolism 10(5): 392-404. doi: 10.1016/j.cmet.2009.09.009.
55. Kim, A.Y., C.G. Lee, Y. da Lee, H. Li, R. Jeon, J.H. Ryu, and S.G. Kim. 2012. Enhanced antioxidant effect of prenylated polyphenols as Fyn inhibitor. Free Radical Biology and Medicine 53(5): 1198-1208. doi: 10.1016/j.freeradbiomed.2012.06.039.
56. Kim, H.S., V. Montana, H.J. Jang, V. Parpura, and J.A. Kim. 2013. Epigallocatechin gallate (EGCG) stimulates autophagy in vascular endothelial cells: A potential role for reducing lipid accumulation. Journal of Biological Chemistry 288(31): 22693-22705. doi: 10.1074/jbc.M113.477505.
57. Kim, Y.W., Y.M. Kim, Y.M. Yang, T.H. Kim, S.J. Hwang, J.R. Lee, S.C. Kim, and S.G. Kim. 2010. Inhibition of SREBP-1c-mediated hepatic steatosis and oxidative stress by sauchinone, an AMPK-activating lignan in Saururus chinensis. Free Radical Biology and Medicine 48(4): 567-578. doi: 10.1016/j.freeradbiomed.2009.12.006.
58. Kim, Y.W., S.M. Lee, S.M. Shin, S.J. Hwang, J.S. Brooks, H.E. Kang, M.G. Lee, S.C. Kim, and S.G. Kim. 2009. Efficacy of sauchinone as a novel AMPK-activating lignan for preventing iron-induced oxidative stress and liver injury. Free Radical Biology and Medicine 47(7): 1082-1092. doi: 10.1016/j.freeradbiomed.2009.07.018.
59. Ko, H.H., M.H. Yen, R.R. Wu, S.J. Won, and C.N. Lin. 1999. Cytotoxic isoprenylated flavans of Broussonetia kazinoki. Journal of Natural Products 62(1): 164-166. doi: 10.1021/np980281c.
60. Koo, J.H., W.H. Lee, C.G. Lee, and S.G. Kim. 2012. Fyn inhibition by cycloalkane-fused 1,2-dithiole-3-thiones enhances antioxidant capacity and protects mitochondria from oxidative injury. Molecular Pharmacology 82(1): 27-36. doi: 10.1124/mol.111.077149.
61. Kook, D., A.H. Wolf, A.L. Yu, A.S. Neubauer, S.G. Priglinger, A. Kampik, and U.C. Welge-Lussen. 2008. The protective effect of quercetin against oxidative stress in the human RPE in vitro. Investigative Ophthalmology & Visual Science 49(4): 1712-1720. doi: 10.1167/iovs.07-0477.
62. Lage, R., C. Dieguez, A. Vidal-Puig, and M. Lopez. 2008. AMPK: A metabolic gauge regulating whole-body energy homeostasis. Trends in Molecular Medicine 14(12): 539-549. doi: 10.1016/j.molmed.2008.09.007.
63. Lan, F., J.M. Cacicedo, N. Ruderman, and Y. Ido. 2008. SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation. Journal of Biological Chemistry 283(41): 27628-27635. doi: 10.1074/jbc.M805711200.
64. Landete, J.M. 2012. Updated knowledge about polyphenols: Functions, bioavailability, metabolism, and health. Critical Reviews in Food Science and Nutrition 52(10): 936-948. doi: 10.1080/10408398.2010.513779.
65. Lang, D.R., and E. Racker. 1974. Effects of quercetin and F1 inhibitor on mitochondrial ATPase and energy-linked reactions in submitochondrial particles. Biochimica et Biophysica Acta 333(2): 180-186.
66. Lee, C.G., Y.W. Kim, E.H. Kim, Z. Meng, W. Huang, S.J. Hwang, and S.G. Kim. 2012. Farnesoid X receptor protects hepatocytes from injury by repressing miR-199a-3p, which increases levels of LKB1. Gastroenterology 142(5): 1206-1217.
67. Lee, Y.S., W.S. Kim, K.H. Kim, M.J. Yoon, H.J. Cho, Y. Shen, J.M. Ye, C.H. Lee, W.K. Oh, C.T. Kim, C. Hohnen-Behrens, A. Gosby, E.W. Kraegen, D.E. James, and J.B. Kim. 2006. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes 55(8): 2256-2264. doi: 10.2337/db06-0006.
68. Li, B., D.S. Lee, H.G. Choi, K.S. Kim, D.G. Kang, H.S. Lee, G.S. Jeong, and Y.C. Kim. 2011. Sauchinone suppresses pro-inflammatory mediators by inducing heme oxygenase-1 in RAW264.7 macrophages. Biological & Pharmaceutical Bulletin 34(10): 1566-1571.
69. Li, C., and J.F. Keaney Jr. 2010. AMP-activated protein kinase: A stress-responsive kinase with implications for cardiovascular disease. Current Opinion in Pharmacology 10(2): 111-115. doi: 10.1016/j.coph.2009.11.009.
70. Lindsay, J., D. Laurin, R. Verreault, R. Hebert, B. Helliwell, G.B. Hill, and I. McDowell. 2002. Risk factors for Alzheimer's disease: A prospective analysis from the Canadian study of health and aging. American Journal of Epidemiology 156(5): 445-453.
71. Liu, G., M. Grifman, J. Macdonald, P. Moller, F. Wong-Staal, and Q.X. Li. 2007. Isoginkgetin enhances adiponectin secretion from differentiated adiposarcoma cells via a novel pathway involving AMP-activated protein kinase. Journal of Endocrinology 194(3): 569-578. doi: 10.1677/JOE-07-0200.
72. Liu, Y.L., B.D. Roebuck, J.D. Yager, J.D. Groopman, and T.W. Kensler. 1988. Protection by 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) against the hepatotoxicity of aflatoxin B1 in the rat. Toxicology and Applied Pharmacology 93(3): 442-451.
73. Lopez-Garcia, E., R.M. van Dam, W.C. Willett, E.B. Rimm, J.E. Manson, M.J. Stampfer, K.M. Rexrode, and F.B. Hu. 2006. Coffee consumption and coronary heart disease in men and women: A prospective cohort study. Circulation 113(17): 2045-2053. doi: 10.1161/circulationaha.105.598664.
74. Lu, J., D.M. Wu, Y.L. Zheng, B. Hu, Z.F. Zhang, Q. Shan, Z.H. Zheng, C.M. Liu, and Y.J. Wang. 2010. Quercetin activates AMP-activated protein kinase by reducing PP2C expression protecting old mouse brain against high cholesterol-induced neurotoxicity. The Journal of Pathology 222(2): 199-212. doi: 10.1002/path.2754.
75. Luttrell, D.K., and L.M. Luttrell. 2004. Not so strange bedfellows: G-protein-coupled receptors and Src family kinases. Oncogene 23(48): 7969-7978. doi: 10.1038/sj.onc.1208162.
76. Maloney, A., and P. Workman. 2002. HSP90 as a new therapeutic target for cancer therapy: The story unfolds. Expert Opinion on Biological Therapy 2(1): 3-24. doi: 10.1517/14712598.2.1.3.
77. Manach, C., A. Scalbert, C. Morand, C. Remesy, and L. Jimenez. 2004. Polyphenols: Food sources and bioavailability. American Journal of Clinical Nutrition 79(5): 727-747.
78. Mastick, C.C., and A.R. Saltiel. 1997. Insulin-stimulated tyrosine phosphorylation of caveolin is specific for the differentiated adipocyte phenotype in 3T3-L1 cells. Journal of Biological Chemistry 272(33): 20706-20714.
79. McKay, M.M., and D.K. Morrison. 2007. Integrating signals from RTKs to ERK/MAPK. Oncogene 26(22): 3113-3121. doi: 10.1038/sj.onc.1210394.
80. McKenna, E., J.S. Smith, K.E. Coll, E.K. Mazack, E.J. Mayer, J. Antanavage, R.T. Wiedmann, and R.G. Johnson Jr. 1996. Dissociation of phospholamban regulation of cardiac sarcoplasmic reticulum Ca2 + ATPase by quercetin. Journal of Biological Chemistry 271(40): 24517-24525.
81. Mokhber-Dezfuli, N., S. Saeidnia, A.R. Gohari, and M. Kurepaz-Mahmoodabadi. 2014. Phytochemistry and pharmacology of berberis species. Pharmacognosy Reviews 8(15): 8-15. doi: 10.4103/0973-7847.125517.
82. Niture, S.K., A.K. Jain, P.M. Shelton, and A.K. Jaiswal. 2011. Src subfamily kinases regulate nuclear export and degradation of transcription factor Nrf2 to switch off Nrf2-mediated antioxidant activation of cytoprotective gene expression. Journal of Biological Chemistry 286(33): 28821-28832. doi: 10.1074/jbc.M111.255042.
83. Ong, K.C., and H.E. Khoo. 1997. Biological effects of myricetin. General Pharmacology 29(2): 121-126.
84. Osterhout, D.J., A. Wolven, R.M. Wolf, M.D. Resh, and M.V. Chao. 1999. Morphological differentiation of oligodendrocytes requires activation of Fyn tyrosine kinase. Journal of Cell Biology 145(6): 1209-1218.
85. Parravicini, V., M. Gadina, M. Kovarova, S. Odom, C. Gonzalez-Espinosa, Y. Furumoto, S. Saitoh, L.E. Samelson, J.J. O'Shea, and J. Rivera. 2002. Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation. Nature Immunology 3(8): 741-748. doi: 10.1038/ni817.
86. Price, N.L., A.P. Gomes, A.J. Ling, F.V. Duarte, A. Martin-Montalvo, B.J. North, B. Agarwal, L. Ye, G. Ramadori, J.S. Teodoro, B.P. Hubbard, A.T. Varela, J.G. Davis, B. Varamini, A. Hafner, R. Moaddel, A.P. Rolo, R. Coppari, C.M. Palmeira, R. de Cabo, J.A. Baur, and D.A. Sinclair. 2012. SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Cell Metabolism 15(5): 675-690. doi: 10.1016/j.cmet.2012.04.003.
87. Roebuck, B.D., T.J. Curphey, Y. Li, K.J. Baumgartner, S. Bodreddigari, J. Yan, S.J. Gange, T.W. Kensler, and T.R. Sutter. 2003. Evaluation of the cancer chemopreventive potency of dithiolethione analogs of oltipraz. Carcinogenesis 24(12): 1919-1928. doi: 10.1093/carcin/bgg173.
88. Rosenzweig, T., S. Aga-Mizrachi, A. Bak, and S.R. Sampson. 2004. Src tyrosine kinase regulates insulin-induced activation of protein kinase C (PKC) delta in skeletal muscle. Cellular Signalling 16(11): 1299-1308. doi: 10.1016/j.cellsig.2004.03.015.
89. Ross, J.A., and C.M. Kasum. 2002. Dietary flavonoids: Bioavailability, metabolic effects, and safety. Annual Review of Nutrition 22: 19-34. doi: 10.1146/annurev.nutr.22.111401.144957.
90. Sanchez-Wandelmer, J., A. Davalos, E. Herrera, M. Giera, S. Cano, G. de la Pena, M.A. Lasuncion, and R. Busto. 2009. Inhibition of cholesterol biosynthesis disrupts lipid raft/caveolae and affects insulin receptor activation in 3T3-L1 preadipocytes. Biochimica et Biophysica Acta 1788(9): 1731-1739. doi: 10.1016/j.bbamem.2009.05.002.
91. Sanguinetti, A.R., H. Cao, and C. Corley Mastick. 2003. Fyn is required for oxidative- and hyperosmotic-stress-induced tyrosine phosphorylation of caveolin-1. Biochemical Journal 376(Pt 1): 159-168. doi: 10.1042/bj20030336.
92. Serrano, J.C., H. Gonzalo-Benito, M. Jove, S. Fourcade, A. Cassanye, J. Boada, M.A. Delgado, A.E. Espinel, R. Pamplona, and M. Portero-Otin. 2013. Dietary intake of green tea polyphenols regulates insulin sensitivity with an increase in AMP-activated protein kinase alpha content and changes in mitochondrial respiratory complexes. Molecular Nutrition & Food Research 57(3): 459-470. doi: 10.1002/mnfr.201200513.
93. Shin, S.M., I.J. Cho, and S.G. Kim. 2009. Resveratrol protects mitochondria against oxidative stress through AMP-activated protein kinase-mediated glycogen synthase kinase-3beta inhibition downstream of poly(ADP-ribose)polymerase-LKB1 pathway. Molecular Pharmacology 76(4): 884-895. doi: 10.1124/mol.109.058479.
94. Shin, S.M., and S.G. Kim. 2009. Inhibition of arachidonic acid and iron-induced mitochondrial dysfunction and apoptosis by oltipraz and novel 1,2-dithiole-3-thione congeners. Molecular Pharmacology 75(1): 242-253. doi: 10.1124/mol.108.051128.
95. Singh, B.N., S. Shankar, and R.K. Srivastava. 2011. Green tea catechin, epigallocatechin-3-gallate (EGCG): Mechanisms, perspectives and clinical applications. Biochemical Pharmacology 82(12): 1807-1821. doi: 10.1016/j.bcp.2011.07.093.
96. Songyang, Z., K.L. Carraway 3rd, M.J. Eck, S.C. Harrison, R.A. Feldman, M. Mohammadi, J. Schlessinger, S.R. Hubbard, D.P. Smith, C. Eng, et al. 1995. Catalytic specificity of protein-tyrosine kinases is critical for selective signalling. Nature 373(6514): 536-539. doi: 10.1038/373536a0.
97. Songyang, Z., S.E. Shoelson, M. Chaudhuri, G. Gish, T. Pawson, W.G. Haser, F. King, T. Roberts, S. Ratnofsky, R.J. Lechleider, et al. 1993. SH2 domains recognize specific phosphopeptide sequences. Cell 72(5): 767-778.
98. Stapleton, D., K.I. Mitchelhill, G. Gao, J. Widmer, B.J. Michell, T. Teh, C.M. House, C.S. Fernandez, T. Cox, L.A. Witters, and B.E. Kemp. 1996. Mammalian AMP-activated protein kinase subfamily. Journal of Biological Chemistry 271(2): 611-614.
99. Sun, X.J., S. Pons, T. Asano, M.G. Myers Jr, E. Glasheen, and M.F. White. 1996. The Fyn tyrosine kinase binds Irs-1 and forms a distinct signaling complex during insulin stimulation. Journal of Biological Chemistry 271(18): 10583-10587.
100. Sung, S.H., and Y.C. Kim. 2000. Hepatoprotective diastereomeric lignans from Saururus chinensis herbs. Journal of Natural Products 63(7): 1019-1021.
101. Suzuki, T., D. Bridges, D. Nakada, G. Skiniotis, S.J. Morrison, J.D. Lin, A.R. Saltiel, and K. Inoki. 2013. Inhibition of AMPK catabolic action by GSK3. Molecular Cell 50(3): 407-419. doi: 10.1016/j.molcel.2013.03.022.
102. Tan, M.J., J.M. Ye, N. Turner, C. Hohnen-Behrens, C.Q. Ke, C.P. Tang, T. Chen, H.C. Weiss, E.R. Gesing, A. Rowland, D.E. James, and Y. Ye. 2008. Antidiabetic activities of triterpenoids isolated from bitter melon associated with activation of the AMPK pathway. Chemistry & Biology 15(3): 263-273. doi: 10.1016/j.chembiol.2008.01.013.
103. Terai, K., Y. Hiramoto, M. Masaki, S. Sugiyama, T. Kuroda, M. Hori, I. Kawase, and H. Hirota. 2005. AMP-activated protein kinase protects cardiomyocytes against hypoxic injury through attenuation of endoplasmic reticulum stress. Molecular and Cellular Biology 25(21): 9554-9575. doi: 10.1128/MCB.25.21.9554-9575.2005.
104. Tse, M.C., X. Liu, S. Yang, K. Ye, and C.B. Chan. 2013. Fyn regulates adipogenesis by promoting PIKE-A/STAT5a interaction. Molecular and Cellular Biology 33(9): 1797-1808. doi: 10.1128/mcb.01410-12.
105. Turner, N., J.Y. Li, A. Gosby, S.W. To, Z. Cheng, H. Miyoshi, M.M. Taketo, G.J. Cooney, E.W. Kraegen, D.E. James, L.H. Hu, J. Li, and J.M. Ye. 2008. Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: A mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action. Diabetes 57(5): 1414-1418. doi: 10.2337/db07-1552.
106. Umemori, H., Y. Kadowaki, K. Hirosawa, Y. Yoshida, K. Hironaka, H. Okano, and T. Yamamoto. 1999. Stimulation of myelin basic protein gene transcription by Fyn tyrosine kinase for myelination. Journal of Neuroscience 19(4): 1393-1397.
107. van Dam, R.M., and F.B. Hu. 2005. Coffee consumption and risk of type 2 diabetes: A systematic review. JAMA 294(1): 97-104. doi: 10.1001/jama.294.1.97.
108. Vatish, M., E. Yamada, J.E. Pessin, and C.C. Bastie. 2009. Fyn kinase function in lipid utilization: A new upstream regulator of AMPK activity? Archives of Physiology and Biochemistry 115(4): 191-198. doi: 10.1080/13813450903164348.
109. Wang, T.T., N. Sathyamoorthy, and J.M. Phang. 1996. Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis 17(2): 271-275.
110. Woods, A., K. Dickerson, R. Heath, S.P. Hong, M. Momcilovic, S.R. Johnstone, M. Carlson, and D. Carling. 2005. Ca2 +/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metabolism 2(1): 21-33. doi: 10.1016/j.cmet.2005.06.005.
111. Woods, A., S.R. Johnstone, K. Dickerson, F.C. Leiper, L.G. Fryer, D. Neumann, U. Schlattner, T. Wallimann, M. Carlson, and D. Carling. 2003. LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Current Biology 13(22): 2004-2008.
112. Wu, L.X., J.H. Xu, X.W. Huang, K.Z. Zhang, C.X. Wen, and Y.Z. Chen. 2006. Down-regulation of p210(bcr/abl) by curcumin involves disrupting molecular chaperone functions of Hsp90. Acta Pharmacologica Sinica 27(6): 694-699. doi: 10.1111/j.1745-7254.2006.00326.x.
113. Xie, M., D. Zhang, J.R. Dyck, Y. Li, H. Zhang, M. Morishima, D.L. Mann, G.E. Taffet, A. Baldini, D.S. Khoury, and M.D. Schneider. 2006. A pivotal role for endogenous TGF-beta-activated kinase-1 in the LKB1/AMP-activated protein kinase energy-sensor pathway. Proceedings of the National Academy of Sciences of the United States of America 103(46): 17378-17383. doi: 10.1073/pnas.0604708103.
114. Xu, Y., L. Nie, Y.G. Yin, J.L. Tang, J.Y. Zhou, D.D. Li, and S.W. Zhou. 2012. Resveratrol protects against hyperglycemia-induced oxidative damage to mitochondria by activating SIRT1 in rat mesangial cells. Toxicology and Applied Pharmacology 259(3): 395-401. doi: 10.1016/j.taap.2011.09.028.
115. Yamada, E., J.E. Pessin, I.J. Kurland, G.J. Schwartz, and C.C. Bastie. 2010. Fyn-dependent regulation of energy expenditure and body weight is mediated by tyrosine phosphorylation of LKB1. Cell Metabolism 11(2): 113-124. doi: 10.1016/j.cmet.2009.12.010.
116. Yan, G.R., C.L. Xiao, G.W. He, X.F. Yin, N.P. Chen, Y. Cao, and Q.Y. He. 2010. Global phosphoproteomic effects of natural tyrosine kinase inhibitor, genistein, on signaling pathways. Proteomics 10(5): 976-986. doi: 10.1002/pmic.200900662.
117. Yang, Y.M., C.Y. Han, Y.J. Kim, and S.G. Kim. 2010. AMPK-associated signaling to bridge the gap between fuel metabolism and hepatocyte viability. World Journal of Gastroenterology 16(30): 3731-3742.
118. Zhang, Q., X. Xiao, K. Feng, T. Wang, W. Li, T. Yuan, X. Sun, Q. Sun, H. Xiang, and H. Wang. 2011. Berberine moderates glucose and lipid metabolism through multipathway mechanism. Evidence-Based Complementary and Alternative Medicine 2011: 924851. doi: 10.1155/2011/924851.
119. Zhang, Y., and R. Munday. 2008. Dithiolethiones for cancer chemoprevention: Where do we stand? Molecular Cancer Therapeutics 7(11): 3470-3479. doi: 10.1158/1535-7163.mct-08-0625.
120. Zhou, J., B.L. Farah, R.A. Sinha, Y. Wu, B.K. Singh, B.H. Bay, C.S. Yang, and P.M. Yen. 2014. Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, stimulates hepatic autophagy and lipid clearance. PLoS One 9(1): e87161. doi: 10.1371/journal.pone.0087161.
121. Zhu, H., Z. Jia, K. Zhou, H.P. Misra, A. Santo, K.L. Gabrielson, and Y. Li. 2009. Cruciferous dithiolethione-mediated coordinated induction of total cellular and mitochondrial antioxidants and phase 2 enzymes in human primary cardiomyocytes: Cytoprotection against oxidative/electrophilic stress and doxorubicin toxicity. Experimental Biology and Medicine (Maywood) 234(4): 418-429. doi: 10.3181/0811-rm-340.